Essentra Valuation

Is ESNTL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ESNTL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ESNTL (£1.5) is trading below our estimate of fair value (£1.79)

Significantly Below Fair Value: ESNTL is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ESNTL?

Other financial metrics that can be useful for relative valuation.

ESNTL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA13.2x
PEG Ratio325.4x

Price to Sales Ratio vs Peers

How does ESNTL's PS Ratio compare to its peers?

The above table shows the PS ratio for ESNTL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.5x
ZTF Zotefoams
1.4x6.6%UK£182.3m
SYNT Synthomer
0.1x5.0%UK£282.6m
ITX Itaconix
3.1x32.2%UK£15.8m
ELM Elementis
1.4x3.4%UK£815.3m
ESNTL Essentra
1.4x1.8%UK£427.7m

Price-To-Sales vs Peers: ESNTL is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (1.5x).


Price to Earnings Ratio vs Industry

How does ESNTL's PE Ratio compare vs other companies in the GB Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a28.0%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a28.0%
n/an/an/a
No more companies

Price-To-Sales vs Industry: ESNTL is expensive based on its Price-To-Sales Ratio (1.4x) compared to the UK Chemicals industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is ESNTL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ESNTL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.4x
Fair PS Ratio1.2x

Price-To-Sales vs Fair Ratio: ESNTL is expensive based on its Price-To-Sales Ratio (1.4x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ESNTL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£1.49
UK£2.24
+50.4%
19.2%UK£3.15UK£1.85n/a6
Oct ’25UK£1.50
UK£2.29
+52.4%
18.9%UK£3.15UK£1.85n/a6
Sep ’25UK£1.77
UK£2.63
+48.6%
12.9%UK£3.15UK£2.20n/a6
Aug ’25UK£1.69
UK£2.63
+55.8%
12.7%UK£3.15UK£2.20n/a6
Jul ’25UK£1.61
UK£2.65
+64.8%
12.4%UK£3.15UK£2.20n/a6
Jun ’25UK£1.64
UK£2.61
+58.6%
12.4%UK£3.15UK£2.20n/a7
May ’25UK£1.77
UK£2.61
+47.5%
12.4%UK£3.15UK£2.20n/a7
Apr ’25UK£1.76
UK£2.61
+48.1%
12.4%UK£3.15UK£2.20n/a7
Mar ’25UK£1.71
UK£2.63
+54.0%
11.8%UK£3.15UK£2.20n/a7
Feb ’25UK£1.72
UK£2.63
+53.0%
11.8%UK£3.15UK£2.20n/a7
Jan ’25UK£1.67
UK£2.61
+56.3%
12.1%UK£3.15UK£2.20n/a7
Dec ’24UK£1.51
UK£2.61
+72.2%
12.1%UK£3.15UK£2.20n/a7
Nov ’24UK£1.55
UK£2.61
+68.4%
12.1%UK£3.15UK£2.20n/a7
Oct ’24UK£1.63
UK£2.69
+65.4%
9.9%UK£3.15UK£2.30UK£1.507
Sep ’24UK£1.48
UK£2.68
+81.2%
10.1%UK£3.15UK£2.30UK£1.777
Aug ’24UK£1.59
UK£2.77
+74.7%
7.6%UK£3.15UK£2.55UK£1.697
Jul ’24UK£1.63
UK£2.77
+70.0%
7.6%UK£3.15UK£2.55UK£1.617
Jun ’24UK£1.81
UK£2.77
+53.5%
7.6%UK£3.15UK£2.55UK£1.647
May ’24UK£2.06
UK£2.80
+35.9%
7.6%UK£3.15UK£2.55UK£1.776
Apr ’24UK£1.94
UK£2.82
+45.5%
8.1%UK£3.15UK£2.55UK£1.765
Mar ’24UK£2.23
UK£2.98
+33.9%
3.8%UK£3.15UK£2.80UK£1.715
Feb ’24UK£2.20
UK£2.98
+35.5%
3.8%UK£3.15UK£2.80UK£1.725
Jan ’24UK£2.38
UK£3.03
+27.1%
2.5%UK£3.15UK£2.95UK£1.674
Dec ’23UK£2.50
UK£2.98
+19.6%
0.8%UK£3.00UK£2.95UK£1.513
Nov ’23UK£2.24
UK£2.90
+29.8%
3.7%UK£3.00UK£2.75UK£1.553
Oct ’23UK£1.82
UK£3.76
+106.3%
18.8%UK£4.95UK£3.10UK£1.634

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies